EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Tenofovir Nephrotoxicity: 2011 Update

Beatriz Fernandez-Fernandez, Ana Montoya-Ferrer, Ana B Sanz, Maria D Sanchez-Niño, Maria C Izquierdo, Jonay Poveda, Valeria Sainz-Prestel, Natalia Ortiz-Martin, Alejandro Parra-Rodriguez, Rafael Selgas, Marta Ruiz-Ortega, Jesus Egido und 1 weitere

AIDS Research and Treatment · 2011

DOI: 10.1155/2011/354908 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS Research and Treatment, 2011. Verfasst von Beatriz Fernandez-Fernandez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nefrología, IIS-Fundacion Jimenez Diaz, Fundacion Renal Iñigo Alvarez de Toledo/Instituto Reina Sofia de Investigacion Nefrologica (FRIAT/IRSIN), Uni…. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tenofovir is an acyclic nucleotide analogue reverse-transcriptase inhibitor structurally similar to the nephrotoxic drugs adefovir and cidofovir. Tenofovir is widely used to treat HIV infection and approved for treatment of hepatitis B virus. Despite initial cell culture and clinical trials results supporting the renal safety of tenofovir, its clinical use is associated with a low, albeit significant, risk of kidney injury. Proximal tubular cell secretion of tenofovir explains the accumulation of the drug in these mitochondria-rich cells. Tenofovir nephrotoxicity is characterized by proximal tubular cell dysfunction that may be associated with acute kidney injury or chronic kidney disease. Withdrawal of the drug leads to improvement of analytical parameters that may be partial. Understanding the risk factors for nephrotoxicity and regular monitoring of proximal tubular dysfunction and serum creatinine in high-risk patients is required to minimize nephrotoxicity. Newer, structurally similar molecular derivatives that do not accumulate in proximal tubules are under study.

Autor:innen und Institutionen

  • Nefrología, IIS-Fundacion Jimenez Diaz, Fundacion Renal Iñigo Alvarez de Toledo/Instituto Reina Sofia de Investigacion Nefrologica (FRIAT/IRSIN), Universidad Autonoma de Madrid, Madrid, Spain.

Zitieren

APA

Fernandez-Fernandez, B., Montoya-Ferrer, A., Sanz, A. B., Sanchez-Niño, M. D., Izquierdo, M. C., Poveda, J., Sainz-Prestel, V., Ortiz-Martin, N., Parra-Rodriguez, A., Selgas, R., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2011). Tenofovir Nephrotoxicity: 2011 Update. AIDS Research and Treatment. https://doi.org/10.1155/2011/354908

Vancouver

Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Niño MD, Izquierdo MC, Poveda J, et al. Tenofovir Nephrotoxicity: 2011 Update. AIDS Research and Treatment. 2011. doi:10.1155/2011/354908

BibTeX
@article{FernandezFernandez2011,
  author = {Fernandez-Fernandez, Beatriz and Montoya-Ferrer, Ana and Sanz, Ana B and Sanchez-Niño, Maria D and Izquierdo, Maria C and Poveda, Jonay and Sainz-Prestel, Valeria and Ortiz-Martin, Natalia and Parra-Rodriguez, Alejandro and Selgas, Rafael and Ruiz-Ortega, Marta and Egido, Jesus and Ortiz, Alberto},
  title = {Tenofovir Nephrotoxicity: 2011 Update},
  journal = {AIDS Research and Treatment},
  year = {2011},
  doi = {10.1155/2011/354908}
}
Kostenlos starten →